Literature DB >> 23880136

Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies.

César de la Fuente-Núñez1, Fany Reffuveille, Lucía Fernández, Robert E W Hancock.   

Abstract

Bacteria have evolved the ability to form multicellular, surface-adherent communities called biofilms that allow survival in hostile environments. In clinical settings, bacteria are exposed to various sources of stress, including antibiotics, nutrient limitation, anaerobiosis, heat shock, etc., which in turn trigger adaptive responses in bacterial cells. The combination of this and other defense mechanisms results in the formation of highly (adaptively) resistant multicellular structures that are recalcitrant to host immune clearance mechanisms and very difficult to eradicate with the currently available antimicrobial agents, which are generally developed for the eradication of free-swimming (planktonic) bacteria. However, novel strategies that specifically target the biofilm mode of growth have been recently described, thus providing the basis for future anti-biofilm therapy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23880136     DOI: 10.1016/j.mib.2013.06.013

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  220 in total

1.  Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis.

Authors:  Marta Kamińska; Ardita Aliko; Annelie Hellvard; Ewa Bielecka; Veronika Binder; Agata Marczyk; Jan Potempa; Nicolas Delaleu; Tomasz Kantyka; Piotr Mydel
Journal:  J Periodontol       Date:  2018-12-26       Impact factor: 6.993

2.  High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides.

Authors:  Evan F Haney; Sarah C Mansour; Ashley L Hilchie; César de la Fuente-Núñez; Robert E W Hancock
Journal:  Peptides       Date:  2015-03-31       Impact factor: 3.750

3.  Targeting Enterococcus faecalis biofilms with phage therapy.

Authors:  Leron Khalifa; Yair Brosh; Daniel Gelman; Shunit Coppenhagen-Glazer; Shaul Beyth; Ronit Poradosu-Cohen; Yok-Ai Que; Nurit Beyth; Ronen Hazan
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

Review 4.  Nano-biofilm Arrays as a Novel Universal Platform for Microscale Microbial Culture and High-Throughput Downstream Applications.

Authors:  Anand Srinivasan; Anand K Ramasubramanian; José L Lopez-Ribot
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

5.  Effect of different agents with potential antibiofilm activity on antimicrobial susceptibility of biofilms formed by Staphylococcus spp. isolated from implant-related infections.

Authors:  Diana Molina-Manso; Gema Del-Prado; Enrique Gómez-Barrena; Jose Cordero-Ampuero; Ricardo Fernandez-Roblas; Jaime Esteban
Journal:  J Antibiot (Tokyo)       Date:  2016-02-24       Impact factor: 2.649

6.  Rethinking evolutionary individuality.

Authors:  Marc Ereshefsky; Makmiller Pedroso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

7.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

8.  Impairment of Cronobacter sakazakii and Listeria monocytogenes biofilms by cell-free preparations of lactobacilli of goat milk origin.

Authors:  Niharika Singh; Ravinder Kaur; Brij Pal Singh; Namita Rokana; Gunjan Goel; Anil Kumar Puniya; Harsh Panwar
Journal:  Folia Microbiol (Praha)       Date:  2019-06-19       Impact factor: 2.099

Review 9.  Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation?

Authors:  Nasim Kashef; Michael R Hamblin
Journal:  Drug Resist Updat       Date:  2017-07-26       Impact factor: 18.500

10.  Using anti-biofilm peptides to treat antibiotic-resistant bacterial infections.

Authors:  César de la Fuente-Núñez; Robert E W Hancock
Journal:  Postdoc J       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.